Found 9 matching trials
Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.
PHASE2The purpose of the study is to evaluate the efficacy of IFX-1 treatment as ...
Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum
PHASE2The purpose of this study is to determine whether vilobelimab (development ...
Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
PHASE2The purpose of this study is to determine whether IFX-1 is safe and effecti...
Location
InflaRX Investigational Site
Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA
PHASE2The purpose of this study is to investigate the safety and tolerability of ...
Location
Mayo Clinic Scottsdale
Studying Complement Inhibition in Early, Newly Developing Septic Organ Dysfunction
PHASE2The trial enrolls patients with early severe sepsis or septic shock display...
Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis Suppurativa
PHASE2The trial enrolls patients with moderate to severe Hidradenitis Suppurativa...
Location
ATTIKON University Hospital
Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.
PHASE2This is an open-label, "non comparative", non-randomized, Phase II study. P...
Location
UC San Diego Moores Cancer Center
Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia
PHASE2Phase II \& Phase III:
This is a pragmatic, adaptive, randomized, multicen...
Location
InflaRx Site #1107
Studying Complement Inhibition in Complex Cardiac Surgery
PHASE2The trial enrolls patients undergoing a complex cardiac surgery. The primar...